CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. (Q40076996)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. |
scientific article |
Statements
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway (English)
B-J Zheng
24 September 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference